Lipoprotein and Cardiovascular Diseases Therapy

Dear Colleagues,

Dyslipidemia is a potent and modifiable risk factor for the development of atherosclerotic cardiovascular disease. The main lipoproteins in human circulation are chylomicrons, high density, intermediate density, low density, and very low-density lipoproteins, each with a different composition of lipids and apolipoproteins. There has been increasing attention being paid to apolipoprotein B and lipoprotein (a). Because of the role of apolipoprotein B containing lipoproteins in atherogenesis, the use of lipid-lowering therapy can contribute to cardiovascular disease modification. Currently, cardiovascular disease guidelines recommend targeting low density lipoprotein cholesterol and non-HDL cholesterol with lipid-lowering therapy for cardiovascular disease reduction.

This Special Issue will examine lipoprotein composition, metabolism, molecular pathways, and their contributions to atherogenesis and residual cardiovascular risk. Additionally, this issue will describe lipoprotein targets for drug therapies to counteract cardiovascular disease.

Dr. Verity Ramirez
Dr. Wenliang Song
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.